Cargando…
Possible neuroprotective role of P2X2 in the retina of diabetic rats
BACKGROUND: Purinergic receptors are expressed in different tissues including the retina. These receptors are involved in processes like cell growth, proliferation, activation and survival. ATP is the major activator of P2 receptors. In diabetes, there is a constant ATP production and this rise of A...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898034/ https://www.ncbi.nlm.nih.gov/pubmed/29682007 http://dx.doi.org/10.1186/s13098-018-0332-7 |
_version_ | 1783314057897443328 |
---|---|
author | Mancini, Jorge E. Ortiz, Gustavo Potilinstki, Constanza Salica, Juan P. Lopez, Emiliano S. Croxatto, J. Oscar Gallo, Juan E. |
author_facet | Mancini, Jorge E. Ortiz, Gustavo Potilinstki, Constanza Salica, Juan P. Lopez, Emiliano S. Croxatto, J. Oscar Gallo, Juan E. |
author_sort | Mancini, Jorge E. |
collection | PubMed |
description | BACKGROUND: Purinergic receptors are expressed in different tissues including the retina. These receptors are involved in processes like cell growth, proliferation, activation and survival. ATP is the major activator of P2 receptors. In diabetes, there is a constant ATP production and this rise of ATP leads to a persistent activation of purinergic receptors. Antagonists of these receptors are used to evaluate their inhibition effects. Recently, the P2X2 has been reported to have a neuroprotective role. METHODS: We carried out a study in groups of diabetic and non-diabetic rats (N = 5) treated with intraperitoneal injections of PPADS, at 9 and 24 weeks of diabetes. Control group received only the buffer. Animals were euthanized at 34 weeks of diabetes or at a matching age. Rat retinas were analyzed with immunohistochemistry and western blot using antibodies against GFAP, P2X2, P2Y2 and VEGF-A. RESULTS: Diabetic animals treated with PPADS disclosed a much more extended staining of VEGF-A than diabetics without treatment. A lower protein expression of VEGF-A was found at the retina of diabetic animals without treatment of purinergic antagonists compared to diabetics with the antagonist treatment. Inhibition of P2X2 receptor by PPADS decreases cell death in the diabetic rat retina. CONCLUSION: Results might be useful for better understanding the pathophysiology of diabetic retinopathy. |
format | Online Article Text |
id | pubmed-5898034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58980342018-04-20 Possible neuroprotective role of P2X2 in the retina of diabetic rats Mancini, Jorge E. Ortiz, Gustavo Potilinstki, Constanza Salica, Juan P. Lopez, Emiliano S. Croxatto, J. Oscar Gallo, Juan E. Diabetol Metab Syndr Research BACKGROUND: Purinergic receptors are expressed in different tissues including the retina. These receptors are involved in processes like cell growth, proliferation, activation and survival. ATP is the major activator of P2 receptors. In diabetes, there is a constant ATP production and this rise of ATP leads to a persistent activation of purinergic receptors. Antagonists of these receptors are used to evaluate their inhibition effects. Recently, the P2X2 has been reported to have a neuroprotective role. METHODS: We carried out a study in groups of diabetic and non-diabetic rats (N = 5) treated with intraperitoneal injections of PPADS, at 9 and 24 weeks of diabetes. Control group received only the buffer. Animals were euthanized at 34 weeks of diabetes or at a matching age. Rat retinas were analyzed with immunohistochemistry and western blot using antibodies against GFAP, P2X2, P2Y2 and VEGF-A. RESULTS: Diabetic animals treated with PPADS disclosed a much more extended staining of VEGF-A than diabetics without treatment. A lower protein expression of VEGF-A was found at the retina of diabetic animals without treatment of purinergic antagonists compared to diabetics with the antagonist treatment. Inhibition of P2X2 receptor by PPADS decreases cell death in the diabetic rat retina. CONCLUSION: Results might be useful for better understanding the pathophysiology of diabetic retinopathy. BioMed Central 2018-04-12 /pmc/articles/PMC5898034/ /pubmed/29682007 http://dx.doi.org/10.1186/s13098-018-0332-7 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Mancini, Jorge E. Ortiz, Gustavo Potilinstki, Constanza Salica, Juan P. Lopez, Emiliano S. Croxatto, J. Oscar Gallo, Juan E. Possible neuroprotective role of P2X2 in the retina of diabetic rats |
title | Possible neuroprotective role of P2X2 in the retina of diabetic rats |
title_full | Possible neuroprotective role of P2X2 in the retina of diabetic rats |
title_fullStr | Possible neuroprotective role of P2X2 in the retina of diabetic rats |
title_full_unstemmed | Possible neuroprotective role of P2X2 in the retina of diabetic rats |
title_short | Possible neuroprotective role of P2X2 in the retina of diabetic rats |
title_sort | possible neuroprotective role of p2x2 in the retina of diabetic rats |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898034/ https://www.ncbi.nlm.nih.gov/pubmed/29682007 http://dx.doi.org/10.1186/s13098-018-0332-7 |
work_keys_str_mv | AT mancinijorgee possibleneuroprotectiveroleofp2x2intheretinaofdiabeticrats AT ortizgustavo possibleneuroprotectiveroleofp2x2intheretinaofdiabeticrats AT potilinstkiconstanza possibleneuroprotectiveroleofp2x2intheretinaofdiabeticrats AT salicajuanp possibleneuroprotectiveroleofp2x2intheretinaofdiabeticrats AT lopezemilianos possibleneuroprotectiveroleofp2x2intheretinaofdiabeticrats AT croxattojoscar possibleneuroprotectiveroleofp2x2intheretinaofdiabeticrats AT gallojuane possibleneuroprotectiveroleofp2x2intheretinaofdiabeticrats |